Viking Therapeutics (VKTX) Common Equity (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Common Equity came in at $408.3 million in Q2 2026, down 48.67% year-over-year from $795.5 million in Q2 2025, and down 18.65% quarter-over-quarter from $501.9 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Common Equity (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Common Equity across 13 years of filings, most recently posting $408.3 million for Q2 2026.
- In Q2 2026, Common Equity fell 48.67% year-over-year to $408.3 million; the TTM figure through Jun 2026 stood at $408.3 million (down 48.67% YoY), while the FY2025 annual figure was $639.1 million, down 27.4% from the prior year.
- Common Equity came in at $408.3 million for Q2 2026 at Viking Therapeutics, down from $501.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $933.9 million in Q1 2024 to a low of $134.1 million in Q1 2023.
- Average Common Equity over 5 years is $524.0 million, with a median of $455.1 million recorded in 2026.
- Year-over-year, Common Equity soared 596.6% in 2024 and tumbled 48.67% in 2026.
- Over 5 years, Common Equity stood at $145.3 million in 2022, then surged by 139.76% to $348.4 million in 2023, then surged by 152.65% to $880.3 million in 2024, then decreased by 27.4% to $639.1 million in 2025, then plunged by 36.11% to $408.3 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $408.3 million in Q2 2026, $501.9 million in Q1 2026, and $639.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 106.07 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | 408.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 408.32 Mn |
| Mar 31, 2026 | 501.92 Mn |
| Dec 31, 2025 | 639.06 Mn |
| Sep 30, 2025 | 713.03 Mn |
| Jun 30, 2025 | 795.46 Mn |
| Mar 31, 2025 | 846.92 Mn |
| Dec 31, 2024 | 880.28 Mn |
| Sep 30, 2024 | 911.45 Mn |
| Jun 30, 2024 | 920.98 Mn |
| Mar 31, 2024 | 933.89 Mn |
| Dec 31, 2023 | 348.42 Mn |
| Sep 30, 2023 | 368.24 Mn |
| Jun 30, 2023 | 386.12 Mn |
| Mar 31, 2023 | 134.07 Mn |
| Dec 31, 2022 | 145.32 Mn |
| Sep 30, 2022 | 151.29 Mn |
| Jun 30, 2022 | 165.23 Mn |
| Mar 31, 2022 | 182.27 Mn |
| Dec 31, 2021 | 201.88 Mn |
| Sep 30, 2021 | 213.12 Mn |
API Access
Viking Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();